|
|
Employer Roundtable Highlights Biosimilar Knowledge Gap
|
|
|
By Anna Rose Welch, editor, Biosimilar Development
Though this event encompassed a small cross-section of employers, the discussions and questions asked about biosimilars revealed the topics that need to be considered, reiterated, and regularly reinforced.
|
|
IPR For Biosimilars: Examining The Benefits And Drawbacks
|
|
|
By John L. Abramic, partner, Steptoe & Johnson LLP
Whether Inter Partes Review (IPR) is the right choice for biosimilar developers will depend on the particular circumstances surrounding each drug candidate. But given the benefits of IPR proceedings, they must at least be considered as a potential tool for challenging patents.
|
|
|
Viral Clearance: 7 Chromatography Column Considerations
|
Article
|
By Linnea Troeng,
GE Healthcare Life Sciences
Viral clearance studies are a critical part of the production of biologics. However, performing studies that are accurate and cost-effective can be challenging. Here are seven things to consider while performing your next chromatography viral clearance study.
|
|
|
|
|
|
Festival Of Biologics 2019
October 15 to 17, 2019 | Basel, Switzerland
The Festival of Biologics 2019 will address the strategic and commercial aspects of discovering, developing, and bringing new biologics to patients with high-level, global speakers from Big Pharma, biotech, academia, and industry. We will bring you three days packed full of top-level science, data and case studies, workshops, roundtables, and networking opportunities. With 350 speakers and 1,500 attendees, this is an event not to be missed.
|
|
Connect With Biosimilar Development:
|
|
|
|
|
|
|
|